Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VAN DER SANDE, F. M.
Right arrow Articles by LEUNISSEN, K. M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VAN DER SANDE, F. M.
Right arrow Articles by LEUNISSEN, K. M. L.
J Am Soc Nephrol 10:1303-1308, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

Effect of Intravenous Saline, Albumin, or Hydroxyethylstarch on Blood Volume during Combined Ultrafiltration and Hemodialysis

FRANK M. VAN DER SANDE*, JEROEN P. KOOMAN*, JOS N. M. BARENDREGT*, FRED H. M. NIEMAN{dagger} and KAREL M. L. LEUNISSEN*

* Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands.
{dagger} Staff Bureau, University Hospital Maastricht, Maastricht, The Netherlands.

Correspondence to Dr. Frank M. van der Sande, University Hospital Maastricht, Department of Internal Medicine, P. Debeyelaan 25, P. O. Box 5800, 6202 AZ Maastricht, The Netherlands. Phone: 31 43 3875007; Fax: 31 43 3875006; E-mail: FVS{at}SINT.AZM.NL

Abstract. It is generally advocated to use saline or albumin infusions during symptomatic hypotension during dialysis. However, because of their side effects and/or costs, they are of limited use. Hydroxyethylstarch (HES), a synthetic colloid with a long-standing volume effect, is used in the management of hypovolemia. In this study, the efficacy of three fluids (isotonic saline [0.9%], albumin [20%], and HES [10%]) was assessed during three treatment sessions with combined ultrafiltration and hemodialysis, which differed in the type of fluid given intravenously. Changes in relative blood volume (BV), systolic BP (SBP), and vascular reactivity (venous tone [VT]) were compared. An intravenous infusion of 100 ml of fluid was given when the decrease in BV versus baseline was more than 10% as measured by a continuous optical reflection method. The ultrafiltration was continued. BV decreased significantly versus baseline independent of the intravenous fluid administration in all three treatment sessions. However, when we compared BV values at the end of the dialysis session with those at the time of infusion, BV continued to decrease significantly with saline (change in BV -4.56 ± 2.75%; P < 0.05) and albumin (change in BV - 2.13 ± 2.51%; P < 0.05), but not with HES (change in BV -0.15 ± 2.17%; NS). Between albumin and HES there were no significant differences in changes in BV (NS), whereas between HES and saline (P < 0.05) and between albumin and saline (P < 0.05) the differences in BV changes were significant. SBP remained unchanged within each session. Although SBP tended to decrease more with saline compared to albumin and HES, the difference was not significant. The higher decrease in BV and SBP with saline was counterbalanced by a significantly higher increase in VT, while VT remained unchanged in the other two sessions. It is concluded that HES is a promising fluid in preserving blood volume, comparable to albumin, but superior to saline.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
Evidence-based Colloid Use in the Critically Ill: American Thoracic Society Consensus Statement
Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1247 - 1259.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. A. Knoll, J. A. Grabowski, G. F. Dervin, and K. O'Rourke
A Randomized, Controlled Trial of Albumin versus Saline for the Treatment of Intradialytic Hypotension
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 487 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. de Simone
Left Ventricular Geometry and Hypotension in End-Stage Renal Disease: A Mechanical Perspective
J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2421 - 2427.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. W. Nette, H. P. Krepel, A. H. van den Meiracker, W. Weimar, and R. Zietse
Specific effect of the infusion of glucose on blood volume during haemodialysis
Nephrol. Dial. Transplant., July 1, 2002; 17(7): 1275 - 1280.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. M. VAN DER SANDE, A. J. LUIK, J. P. KOOMAN, V. VERSTAPPEN, and K. M. L. LEUNISSEN
Effect of Intravenous Fluids on Blood Pressure Course during Hemodialysis in Hypotensive-Prone Patients
J. Am. Soc. Nephrol., March 1, 2000; 11(3): 550 - 555.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP